r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

CT

Cameron Turtle

Insider · Chief Executive Officer · SYRE

Cameron Turtle files insider transactions with the SEC as a chief executive officer of Spyre Therapeutics (SYRE). We hold 9 disclosed purchases and sales filed since 6 June 2019, 3 of them in the last 90 days.

  • Files forSYRE
  • Disclosed buys and sells9 in all, 3 in the last 90 days
  • Last disclosure3 September 2026

Positions held

6 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 1 February 2024 — 1 September 2026Chief Executive Officer · Spyre Therapeutics (SYRE)46 Form 4 lines · source: SEC Form 4
  • Filed 23 March 2026 — 23 March 2026Director · Damora Therapeutics (DMRA)2 Form 4 lines · source: SEC Form 4
  • Filed 2 June 2025 — 2 June 2025Director · Oruka Therapeutics (ORKA)1 Form 4 line · source: SEC Form 4
  • Filed 22 November 2023 — 24 November 2023Chief Executive Officer · Spyre Therapeutics (AGLE)3 Form 4 lines · source: SEC Form 4
  • Filed 30 November 2018 — 26 January 2021Chief Business Officer · Eidos Therapeutics (EIDX)59 Form 4 lines · source: SEC Form 4
  • Filed 1 July 2019 — 28 December 2020Officer · BridgeBio Pharma (BBIO)61 Form 4 lines · source: SEC Form 4

Everything they disclosed

120 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.